Reported Standalone quarterly numbers for Suven Life Sciences are:
Net Sales at Rs 2.61 crore in March 2023 down 38.14% from Rs. 4.22 crore in March 2022.
Story continues below Advertisement
Quarterly Net Loss at Rs. 2.25 crore in March 2023 up 73.7% from Rs. 8.55 crore in March 2022.
EBITDA stands negative at Rs. 0.53 crore in March 2023 up 92.8% from Rs. 7.36 crore in March 2022.
Suven Life Sci shares closed at 59.50 on May 08, 2023 (NSE) and has given -2.06% returns over the last 6 months and -25.44% over the last 12 months.
Story continues below Advertisement
| Suven Life Sciences | | Standalone Quarterly Results | in Rs. Cr. |
|
| Mar'23 | Dec'22 | Mar'22 | | Net Sales/Income from operations | 2.61 | 3.00 | 4.22 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 2.61 | 3.00 | 4.22 | | EXPENDITURE | | Consumption of Raw Materials | -- | -- | -- | | Purchase of Traded Goods | -- | -- | -- | | Increase/Decrease in Stocks | -- | -- | -- | | Power & Fuel | -- | -- | -- | | Employees Cost | 3.18 | 4.03 | 5.06 | | Depreciation | 1.67 | 1.67 | 1.10 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | 4.38 | 5.22 | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 1.17 | 0.85 | 6.64 | | P/L Before Other Inc. , Int., Excpt. Items & Tax | -7.80 | -8.77 | -8.57 | | Other Income | 5.60 | 2.20 | 0.12 | | P/L Before Int., Excpt. Items & Tax | -2.20 | -6.57 | -8.46 | | Interest | 0.05 | 0.06 | 0.10 | | P/L Before Exceptional Items & Tax | -2.25 | -6.63 | -8.55 | | Exceptional Items | -- | -- | -- | | P/L Before Tax | -2.25 | -6.63 | -8.55 | | Tax | -- | -- | -- | | P/L After Tax from Ordinary Activities | -2.25 | -6.63 | -8.55 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | -2.25 | -6.63 | -8.55 | | Equity Share Capital | 21.81 | 21.81 | 14.54 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | -0.05 | -0.35 | -0.67 | | Diluted EPS | -0.05 | -0.35 | -0.67 | | EPS After Extra Ordinary | | Basic EPS | -0.05 | -0.35 | -0.67 | | Diluted EPS | -0.05 | -0.35 | -0.67 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
